InMode CFO Sees Demand Stabilizing, Targets Flat 2026 Revenue as North America Rebuild Begins

CFO Yair Malca said the company believes a multi-year downturn in demand is beginning to stabilize, with management expecting ...
Seeking Alpha

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
Seeking Alpha

InMode's Quest For Growth Amidst Aesthetic Adversities

InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...

InMode Announces New Share Repurchase Program

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of ...
MarketWatch

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...
Business Insider

InMode Introduces the Morpheus8 Platform and the Morpheus8 Body Fractional Technology

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to ...
Benzinga.com

InMode Stock Soars After Q2 Earnings: The Details

InMode Ltd INMD reported Q2 sales of $136.1 million, an increase of 20% Y/Y, beating the consensus of $132 million and slightly above the preliminary numbers. Adjusted EPS reached $0.72, compared to ...